Objective: to compare survival, clinical pregnancy and ongoing pregnancy rates of blastocysts vitrified on day 5 and those which had one day delay and vitrified on day 6. Materials & Methods: The study included 210 vitrified warmed cycles, 135 patients underwent vitrifivation at day 5 (group I) and 75 patients at day 6 (group II). Blastocyst survival and clinical pregnancy/embryo transfer were primary outcomes. Ongoing pregnancy/embryo transfer was the secondary outcome. Result(s) blastocyst post-warming survival rates were comparable between both groups (92.9% (263/283) of day 5 versus 94.9% (166/175) of day 6 blastocysts). There was no statistically significant difference between the 2 groups regarding the mean number of transferred blastocysts. Clinical pregnancy rates were 40.6% (52/128) & 43.7% (31/71) in women who undergone vitrification at day 5and day 6 respectively with no significant differences. Similarly, ongoing pregnancy rate was comparable between the 2 groups, 37.5% (48/128) versus 39.4% (28/71) in groups I & II. Conclusion(s): blastocysts vitrified on day 5 have the same survival, clinical and ongoing pregnancy rates of blastocysts which had one day delay and vitrified on day 6.
Elgindy, E. A. (2012). Clinical outcome of day 5 and day 6 blastocyst vitrification. The Egyptian Journal of Fertility and Sterility, 16(1), 9-12. doi: 10.21608/egyfs.2012.257279
MLA
Eman A. Elgindy. "Clinical outcome of day 5 and day 6 blastocyst vitrification", The Egyptian Journal of Fertility and Sterility, 16, 1, 2012, 9-12. doi: 10.21608/egyfs.2012.257279
HARVARD
Elgindy, E. A. (2012). 'Clinical outcome of day 5 and day 6 blastocyst vitrification', The Egyptian Journal of Fertility and Sterility, 16(1), pp. 9-12. doi: 10.21608/egyfs.2012.257279
VANCOUVER
Elgindy, E. A. Clinical outcome of day 5 and day 6 blastocyst vitrification. The Egyptian Journal of Fertility and Sterility, 2012; 16(1): 9-12. doi: 10.21608/egyfs.2012.257279